In T2D, miR-495 inhibited FTO expression, thus promoting the transformation of macrophages into M1-type pro-inflammatory macrophages, and aggravated insulin resistance and adipose tissue inflammation (Hu et al., 2019a). Here, FTO is linked to type 2 diabetes mellitus.